Hypolipidemic effects of HVC1 in a high cholesterol diet‑induced rat model of hyperlipidemia

Kim,Chae‑Yun; Chung,Kyung‑Sook; Cheon,Se‑Yun; Lee,Kyungjin; Ham,Inhye; Choi,Ho‑Young; Cho,Yong Baik; Cho,Byoung‑Heon; Mok,So Youn; An,Hyo‑Jin

doi:10.3892/mmr.2016.5615

Hypolipidemic effects of HVC1 in a high cholesterol diet‑induced rat model of hyperlipidemia

Authors:
- Chae‑Yun Kim
- Kyung‑Sook Chung
- Se‑Yun Cheon
- Kyungjin Lee
- Inhye Ham
- Ho‑Young Choi
- Yong Baik Cho
- Byoung‑Heon Cho
- So Youn Mok
- Hyo‑Jin An
View Affiliations

Affiliations: Department of Pharmacology, College of Oriental Medicine, Sangji University, Wonju, Gangwon‑do 220702, Republic of Korea, Department of Herbology, College of Korean Medicine, Kyung Hee University, Seoul 130701, Republic of Korea, Pharmaceutical R&D Center, Kolmar Korea Co. Ltd, Sejong 339853, Republic of Korea
Published online on: August 9, 2016 https://doi.org/10.3892/mmr.2016.5615
Pages: 3152-3158
Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

HVC1, a novel formation containing four herbs, was developed and its hypolipidemic effects in rats with high cholesterol diet (HCD)‑induced hyperlipidemia were investigated. The rats were given a HCD for 8 weeks. The HVC1‑treated groups were orally administered HVC1 at doses of 10, 50 or 250 mg/kg, respectively, and the simvastatin group was treated at a dose of 10 mg/kg. The normal diet and HCD control groups were administered with physiological saline. Oral administration of HVC1 (10, 50 or 250 mg/kg) significantly reduced the body weight of rats with hyperlipidemia and regulated the total cholesterol, low‑density lipoprotein cholesterol and high‑density lipoprotein cholesterol levels in the serum. In addition, tissue analysis revealed that lipid accumulation in the liver and aorta was reduced by HVC1 administration. Furthermore, HVC1 significantly reduced the mRNA expression of peroxisome proliferator‑activated receptor‑γ, 3‑hydroxy‑3‑methylglutaryl‑CoA reductase and low‑density lipoprotein receptor, as well as the protein level of 5' adenosine monophosphate‑activated protein kinase in the liver. The results clearly demonstrate that HVC1 has a potent hypolipidemic effect, and suggest that HVC1 should be evaluated as a potential treatment for hyperlipidemia.

View Figures

View References

1	Saha SA and Arora RR: Hyperlipidaemia and cardiovascular disease: Do fibrates have a role? Curr Opin Lipidol. 22:270–276. 2011. View Article : Google Scholar : PubMed/NCBI
2	Ahn D: Illustrated book of Korean medicinal herbs. Kyohak Publishing; 1998
3	Kim J: Illustrated natural drugs encyclopedia, colorth edition ed. Namsandang; 1997
4	Lee K, Ham I, Yang G, Lee M, Bu Y, Kim H and Choi HY: Vaso-relaxant effect of Prunus yedoensis bark. BMC Complement Altern Med. 13:312013. View Article : Google Scholar
5	Ahn TG, Yang G, Lee HM, Kim MD, Choi HY, Park KS, Lee SD, Kook YB and An HJ: Molecular mechanisms underlying the anti-obesity potential of prunetin, an O-methylated isoflavone. Biochem Pharmacol. 85:1525–1533. 2013. View Article : Google Scholar : PubMed/NCBI
6	Liu Q, Zhang XL, Tao RY, Niu YJ, Chen XG, Tian JY and Ye F: Rhein, an inhibitor of adipocyte differentiation and adipogenesis. J Asian Nat Prod Res. 13:714–723. 2011. View Article : Google Scholar : PubMed/NCBI
7	Huang Q, Lu G, Shen HM, Chung MC and Ong CN: Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev. 27:609–630. 2007. View Article : Google Scholar
8	Guo MZ, Li XS, Xu HR, Mei ZC, Shen W and Ye XF: Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats. Acta Pharmacol Sin. 23:739–744. 2002.PubMed/NCBI
9	Choi SB, Ko BS, Park SK, Jang JS and Park S: Insulin sensitizing and alpha-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma. Life Sci. 78:934–942. 2006. View Article : Google Scholar
10	Sheng X, Wang M, Lu M, Xi B, Sheng H and Zang YQ: Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice. Am J Physiol Endocrinol Metab. 300:E886–E893. 2011. View Article : Google Scholar : PubMed/NCBI
11	Xie W, Gu D, Li J, Cui K and Zhang Y: Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice. PLoS One. 6:e245202011. View Article : Google Scholar : PubMed/NCBI
12	Xie HC and Shang J: Study on the extraction process of total anthraquinones in Radix et Rhizoma Rhei and their antilipemic effects. Afr J Tradit Complement Altern Med. 11:358–362. 2014. View Article : Google Scholar : PubMed/NCBI
13	Lee IS, Park S, Park K and Choue R: Hepatoprotective activity of scutellariae radix extract in mice fed a high fat diet with chronic alcohol exposure. Phytother Res. 25:1348–1353. 2011.PubMed/NCBI
14	Bak EJ, Kim J, Choi YH, Kim JH, Lee DE, Woo GH, Cha JH and Yoo YJ: Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice. Clin Nutr. 33:156–163. 2014. View Article : Google Scholar
15	Nunnari JJ, Zand T, Joris I and Majno G: Quantitation of oil red O staining of the aorta in hypercholesterolemic rats. Exp Mol Pathol. 51:1–8. 1989. View Article : Google Scholar : PubMed/NCBI
16	Lee K, Kim B, Hur H, Chinannai KS, Ham I and Choi HY: Antihypertensive effect of the GaMiSamHwangSaSimTang in spontaneous hypertensive rats. Evid Based Complement Alternat Med. 2015:8023682015. View Article : Google Scholar : PubMed/NCBI
17	Unger RH: The hyperleptinemia of obesity-regulator of caloric surpluses. Cell. 117:145–146. 2004. View Article : Google Scholar : PubMed/NCBI
18	Boruah DC, Devi R, Tamuli S, Kotoky J and Sharma DK: Hypolipidemic activity of crude polyphenols from the leaves of Clerodendron colebrookianum Walp in cholesterol fed rats. J Food Sci Technol. 51:3333–3340. 2014. View Article : Google Scholar
19	Jump DB, Tripathy S and Depner CM: Fatty acid-regulated transcription factors in the liver. Annu Rev Nutr. 33:249–269. 2013. View Article : Google Scholar : PubMed/NCBI
20	Walczak R and Tontonoz P: PPARadigms and PPARadoxes: Expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res. 43:177–186. 2002.PubMed/NCBI
21	Istvan ES and Deisenhofer J: Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 292:1160–1164. 2001. View Article : Google Scholar : PubMed/NCBI
22	Rudling M: Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J Lipid Res. 33:493–501. 1992.PubMed/NCBI
23	Südhof TC, Goldstein JL, Brown MS and Russell DW: The LDL receptor gene: A mosaic of exons shared with different proteins. Science. 228:815–822. 1985. View Article : Google Scholar : PubMed/NCBI
24	Pieper-Fürst U and Lammert F: Low-density lipoprotein receptors in liver: Old acquaintances and a newcomer. Biochim Biophys Acta. 1831:1191–1198. 2013. View Article : Google Scholar : PubMed/NCBI
25	Lim CT, Kola B and Korbonits M: AMPK as a mediator of hormonal signalling. J Mol Endocrinol. 44:87–97. 2010. View Article : Google Scholar